Media Advisory: La Roche-Posay Hosts Skin Cancer Awareness Event and Reveals Initiative to Accelerate Access to Care and Treatment for Patients

MONTREAL, May 11, 2016 /CNW/ - As part of the company's commitment to reducing the instance of skin cancer in Canada, La Roche-Posay is inviting media to its Become a Skin Checker skin cancer awareness event on Thursday, May 12. La Roche-Posay will be holding a press conference to discuss teledermatology, the latest technical innovation in the dermatology field and the future of early skin cancer detection. Teledermatology is the use of a medical device with a smart phone, giving general practitioners the ability to share high-resolution images with a dermatologist, regardless the distance, for evaluation via a secured platform.

At the event, La Roche-Posay and its partners will also offer skin examinations via teledermatology, information on sun safety habits and the ABCDE method of detecting suspicious moles for participants throughout the day.

WHAT

Press conference and skin cancer awareness event for Become a Skin Checker campaign. La Roche-Posay and partners, along with well-known dermatologist Dr. Joël Claveau will talk about teledermatology as efficient patient e-triage tool, and offer examinations for participants via teledermatology.



WHY                      

Since 2000, melanoma has increased 2.4 times faster than other cancers, affecting both men and women at an alarming rate.i As many as one out of three cancers diagnosed in Canada this year will be skin cancer.ii Despite the fact that 90 per cent of skin cancers are curable if detected early, 2 out of 3 Canadians have never had a mole checked by a dermatologist.iii



WHO                     

Josée Bordeleau, Medical Relations Manager, La Roche-Posay
Dr. Joël Claveau, Canadian dermatologist specializing in the diagnosis and treatment of melanoma
Representatives of Centre Médical Urbain (CMU), La Roche-Posay's partner on this initiative
Representatives from MetaOptima, La Roche-Posay's partner on this initiative





WHERE                  

Complexe Desjardins
Grande Place – metro level
150 rue Ste-Catherine W., Montreal H2X 3Y2




WHEN

Thursday, May 12, 2016
The press conference will take place from 9 a.m. to 9:30 a.m., with spokespeople onsite for media interviews until 10 a.m.
The event will be open to consumers all day from 8 a.m. to 6 p.m., with up to 100 free exams of suspicious lesions using teledermatology throughout the day.





VISUALS/INTERVIEW OPPORTUNITY


La Roche-Posay and well-known dermatologist Dr. Joël Claveau speaking at press conference meeting with media representatives and interacting with consumers, leading informative discussions and offering examinations of suspicious lesions via teledermatology.

 

ABOUT LA ROCHE-POSAY
La Roche-Posay is a division of L'Oréal Canada, a wholly-owned subsidiary of L'Oréal Group, the largest cosmetics company in the world. Headquartered in Montreal, L'Oréal Canada had sales of $1.07 billion in 2014 and employs more than 1,200 people. The company's prestigious portfolio of 35 brands encompasses all aspects of beauty.

Through the La Roche-Posay Foundation, under the aegis of the Fondation de France, the brand has been actively supporting research in the clinical, biological and pharmacological fields of dermatology as well as supporting and encouraging generous initiatives from dermatologists.

_____________________________
i Statistics Canada, 2000 & 2014
ii Canadian Skin Cancer Foundation
iii Ipsos 2015

SOURCE La Roche-Posay

For further information: Michèle Fortier, La Force du Collectif, pour La Roche-Posay, T : (514) 282-4637, E : michele.fortier@laforceducollectif.ca

Organization Profile

La Roche-Posay

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890